EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA FOR GENERALIZED MYASTHENIA GRAVIS

First and Only CD19-Targeted Therapy Approved in Europe for Adults with anti-AChR+ and anti-MuSK+ gMGUPLIZNA Demonstrates Durable Disease Control with Twice-Yearly Dosing*THOUSAND OAKS, Calif.
Junior Mining Network

Green Bridge Metals Announces Partnership with APEX to Support Regional Engagement in Minnesota

VANCOUVER, BC / ACCESS Newswire / February 11, 2026 / Green Bridge Metals Corporation (CSE:GRBM) (OTCQB:GBMCF) (FWB:J48, WKN: A3EW4S) ("Green ...